Human chorionic gonadotropin (HCG) and possibly the other members of this glycoprotein hormone family, belong to a structural superfamily of cystineknot growth factors (1) . Like the growth factors in this family, hCG can exert non-mitogenic as well as mitogenic actions in gonadal and non-gonadal repro¬ ductive tissues (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . hCG actions are mediated by transmembrane glycoprotein receptors which belong to the family of G-protein coupled receptors (19) . The members of this family contain an extracellular ligand binding domain, seven transmembrane spanning regions and a cytoplasmic tail (19) . Our (LH) receptor gene (6, 8, 20, 21) . The myometrial receptors increase from proliferative to secretory phase and decrease during postmenopause, suggesting that they are regulated by reproductive hormones (20, 21) . The myometrial receptors are also present during pregnancy, with lower levels during labor compared with not in labor in prêterai or term pregnancies (22) . The myometrial hCG/LH receptors are functional as treatment with exogenous hCG can modestly increase cell numbers and hypertrophy in a subpopulation of cells (6) . In addition, hCG can inhibit oxytocin stimulated myometrial contractions, perhaps by down-regulating myometrial gap junctions (15, 16 Results Figure 1 shows that culturing with 30 nM hCG alone had no effect on myometrial smooth muscle cell density.
Culturing also with 30 nM FSH resulted in a modest and significant increase in cell density (p < 0.01). However, culturing with FSH alone had no effect.
The FSH restoration of mitogenic response of hCG was further investigated by using antibodies (Fig. 2) . As in Fig. 1 Figure 3 shows that FSH treatment resulted in an increase of immunostaining for hCG/LH receptors in myometrial smooth muscle cells (Fig. 3b vs 3a) . The receptor immunostaining is specific, as it is absent when the receptor antibody was preabsorbed with excess receptor peptide (Fig. 3c) (Fig. 3d) , just as rat ovary (Fig. 3f) and human granulosa cells (Fig. 3h) 
